Evidence map›Paper›PMID 24912506›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2014

Physiology and metabolism of tissue-engineered skeletal muscle.

Cindy S Cheng, Brittany N J Davis, Lauran Madden, Nenad Bursac, George A Truskey

Open access · greenAbstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. MEF/KSF-conditioned culture medium: An effective method forExperimental and therapeutic medicine · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. 3D Bioprinting in Skeletal Muscle Tissue Engineering.Small (Weinheim an der Bergstrasse, Germany) · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cindy S ChengDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Brittany N J DavisDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Lauran MaddenDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Nenad BursacDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
George A TruskeyDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA george.truskey@duke.edu.
Duke University · US

Funding

Interaction of Subchondral Bone and Articular Cartilage System with Skeletal MuscleUH3TR000505 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2014 to 2016
$3.6M
Circulatory system and integrated muscle tissue for drug and tissue toxicityUH2TR000505 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2012 to 2013
$2.1M
Translational studies of GAA deficiency in bioengineered human muscleR01AR065873 · NIAMS · DUKE UNIVERSITY · PI BURSAC, NENAD, KOEBERL, DWIGHT D · 2013 to 2017
$1.8M
Engineering a Functional Skeletal MuscleR01AR055226 · NIAMS · DUKE UNIVERSITY · PI BURSAC, NENAD · 2008 to 2012
$1.6M
MicroRNA Mediation of Stretch-Induced Myoblast Function for Engineered TissuesR21AR055195 · NIAMS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2009 to 2010
$384k
NCATS NIH HHS UH2 TR000505NCATS NIH HHS UH2TR000505NCATS NIH HHS UH3 TR000505NIAMS NIH HHS R01 AR055226NIAMS NIH HHS R01AR055226NIAMS NIH HHS R01 AR065873NIAMS NIH HHS R01AR065873NIAMS NIH HHS R21 AR055195NIAMS NIH HHS R21AR055195
6 · The paper itself

Abstract

Skeletal muscle is a major target for tissue engineering, given its relative size in the body, fraction of cardiac output that passes through muscle beds, as well as its key role in energy metabolism and diabetes, and the need for therapies for muscle diseases such as muscular dystrophy and sarcopenia. To date, most studies with tissue-engineered skeletal muscle have utilized murine and rat cell sources. On the other hand, successful engineering of functional human muscle would enable different applications including improved methods for preclinical testing of drugs and therapies. Some of the requirements for engineering functional skeletal muscle include expression of adult forms of muscle proteins, comparable contractile forces to those produced by native muscle, and physiological force-length and force-frequency relations. This review discusses the various strategies and challenges associated with these requirements, specific applications with cultured human myoblasts, and future directions.

Indexed as

Tissue EngineeringAnimalsDrug Evaluation, PreclinicalHumansMuscle, SkeletalMuscular DystrophiesMyoblasts, SkeletalRatsSarcopeniabioreactorscontractile forceMyoblastskeletal muscle myotubetissue engineering

Identifiers

PMID24912506
PMCPMC4156521
OpenAlexW2158095398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.